Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Luis J. Martinez"'
Autor:
Heather Friberg, Morgan Gargulak, Amanda Kong, Leyi Lin, Luis J. Martinez, Alexander C. Schmidt, Robert M. Paris, Richard G. Jarman, Clemente Diaz, Stephen J. Thomas, Philippe Moris, Jeffrey R. Currier
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-10 (2022)
Abstract The increasing global impact of dengue underscores the need for a dengue virus (DENV) vaccine. We assessed B-cell and T-cell responses following vaccination with four formulations of a tetravalent dengue purified inactivated vaccine (DPIV) i
Externí odkaz:
https://doaj.org/article/2046e228a49043bda2bf6939924cdb61
Autor:
Heather Friberg, Luis J. Martinez, Leyi Lin, Jason M. Blaylock, Rafael A. De La Barrera, Alan L. Rothman, J. Robert Putnak, Kenneth H. Eckels, Stephen J. Thomas, Richard G. Jarman, Jeffrey R. Currier
Publikováno v:
mSphere, Vol 5, Iss 1 (2020)
ABSTRACT Dengue is the most prevalent arboviral disease afflicting humans, and a vaccine appears to be the most rational means of control. Dengue vaccine development is in a critical phase, with the first vaccine licensed in some countries where deng
Externí odkaz:
https://doaj.org/article/9a70ddf949f2464fbfa4032091e25a8f
Autor:
Robert Paris, Maribel Campos, Kenneth H. Eckels, Alexander C. Schmidt, Luis J. Martinez, Richard G. Jarman, Irma Febo, Clemente Diaz, David W. Vaughn, Edith Lepine, Michael Koren, Rafael De La Barrera, Stephen J. Thomas, Todd M. Wilson, Leyi Lin
Publikováno v:
The American Journal of Tropical Medicine and Hygiene
Four formulations of an investigational tetravalent dengue purified inactivated vaccine, administered as two doses one month (M) apart, were previously shown to be immunogenic and well-tolerated up to M13 of the phase I study NCT01702857. Here, we re
Autor:
Heather Friberg, Morgan Gargulak, Amanda Kong, Leyi Lin, Luis J. Martinez, Alexander C. Schmidt, Robert M. Paris, Richard G. Jarman, Clemente Diaz, Stephen J. Thomas, Philippe Moris, Jeffrey R. Currier
Publikováno v:
NPJ vaccines. 7(1)
The increasing global impact of dengue underscores the need for a dengue virus (DENV) vaccine. We assessed B-cell and T-cell responses following vaccination with four formulations of a tetravalent dengue purified inactivated vaccine (DPIV) in dengue-
Publikováno v:
Military medicine. 186(3-4)
Autor:
J. Robert Putnak, Jason M. Blaylock, Luis J. Martinez, Jeffrey R. Currier, Leyi Lin, Alan L. Rothman, Rafael De La Barrera, Richard G. Jarman, Stephen J. Thomas, Kenneth H. Eckels, Heather Friberg
Publikováno v:
mSphere, Vol 5, Iss 1 (2020)
mSphere, Vol 5, Iss 1, p e00671-19 (2020)
mSphere
mSphere, Vol 5, Iss 1, p e00671-19 (2020)
mSphere
Dengue is a tropical disease transmitted by mosquitoes, and nearly half of the world’s population lives in areas where individuals are at risk of infection. Several vaccines for dengue are in development, including one which was recently licensed i
Autor:
Jean-François Toussaint, Richard G. Jarman, Stephen J. Thomas, Kristopher M. Paolino, Bruce L. Innis, Richard C. Ruck, Kenneth H. Eckels, Leyi Lin, Alexander C. Schmidt, Edith Lepine, Alix Collard, Rafael De La Barrera, Luis J. Martinez
Publikováno v:
The American Journal of Tropical Medicine and Hygiene
The safety and immunogenicity of four formulations of an investigational tetravalent dengue purified inactivated vaccine (DPIV), formulated at 1 or 4 μg with aluminum hydroxide (alum) or at 1 μg with an adjuvant system (AS01E or AS03B), were evalua
Autor:
Stephen J. Thomas, Luis J. Martinez, Arthur Lyons, Richard G. Jarman, Kenneth H. Eckels, Elisabeth Hesse, Rafael De La Barrera
Publikováno v:
The American Journal of Tropical Medicine and Hygiene
Dengue virus infections have adversely impacted U.S. military operations since the Spanish-American War. The erosion of mission capabilities and lost duty days are underestimated. Appreciating the incidence and prevalence of dengue infections in U.S.
Autor:
Bruce L. Innis, Edith Lepine, Jean-François Toussaint, Richard G. Jarman, Irma Febo, Leyi Lin, Rafael De La Barrera, Luis J. Martinez, Stephen J. Thomas, Maribel Campos, Kenneth H. Eckels, Clemente Diaz, Alexander C. Schmidt
Publikováno v:
The American Journal of Tropical Medicine and Hygiene
The safety and immunogenicity of four adjuvanted formulations of an investigational tetravalent dengue purified inactivated vaccine (DPIV) were evaluated in a predominantly dengue-primed population in Puerto Rico. In this placebo-controlled, randomiz
Publikováno v:
Mayo Clinic Proceedings. 83:574-579
Q fever, a zoonosis caused by Coxiella burnetii, is seen throughout the world. Recent reports suggest that its incidence in the United States is increasing, with more than 30 cases reported in the US military. The disease has many acute and chronic m